ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

ASCO Names Stratetic Planning Committee

September 23, 1988

Tobacco Council Announces 12 New Awards, Six Relating To Smoking

August 2, 1974

UCSF Receives $125 Million Gift for Cancer Hospital

March 27, 2009

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

Also: Court Will Reconsider Ruling on Access To Experimental Drugs.

December 1, 2006

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005